APA

Medina-Rivero E., Balderas-Hernández V. E., Ordoñez-Acevedo L. G., Paz-Maldonado L. M. T., Barba-De la Rosa A. P. & De León-Rodríguez A. (20071113). Modified penicillin acylase signal peptide allows the periplasmic production of soluble human interferon-gamma but not of soluble human interleukin-2 by the Tat pathway in Escherichia coli. : Biotechnology letters.

Chicago

Medina-Rivero E, Balderas-Hernández V E, Ordoñez-Acevedo L G, Paz-Maldonado L M T, Barba-De la Rosa A P and De León-Rodríguez A. 20071113. Modified penicillin acylase signal peptide allows the periplasmic production of soluble human interferon-gamma but not of soluble human interleukin-2 by the Tat pathway in Escherichia coli. : Biotechnology letters.

Harvard

Medina-Rivero E., Balderas-Hernández V. E., Ordoñez-Acevedo L. G., Paz-Maldonado L. M. T., Barba-De la Rosa A. P. and De León-Rodríguez A. (20071113). Modified penicillin acylase signal peptide allows the periplasmic production of soluble human interferon-gamma but not of soluble human interleukin-2 by the Tat pathway in Escherichia coli. : Biotechnology letters.

MLA

Medina-Rivero E, Balderas-Hernández V E, Ordoñez-Acevedo L G, Paz-Maldonado L M T, Barba-De la Rosa A P and De León-Rodríguez A. Modified penicillin acylase signal peptide allows the periplasmic production of soluble human interferon-gamma but not of soluble human interleukin-2 by the Tat pathway in Escherichia coli. : Biotechnology letters. 20071113.